In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 91 to 100 of 382

TitleTypeExpected publication date
Deutetrabenazine for treating tardive dyskinesia ID6550Technology appraisal guidanceTBC
Dexmedetomidine for treating agitation associated with bipolar disorder in people 18 to 75 years [TS ID 10725]Technology appraisal guidanceTBC
Dexmedetomidine for treating agitation associated with schizophrenia TS ID 10726Technology appraisal guidanceTBC
Diabetic retinopathy - ruboxistaurin [ID382]Technology appraisal guidanceTBC
Digital platforms to support cardiac rehabilitation: early value assessmentHealth technology evaluation
Digital self-help for eating disorders: early value assessmentHealth technology evaluation
Digital technologies for managing mild to moderate hip or knee osteoarthritis: early-value assessmentHealth technology evaluation
Digital technologies to support asthma self-management: early value assessmentHealth technology evaluation
Digital technologies to support smoking cessation in secondary care patients: early value assessmentHealth technology evaluationTBC
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All